In the current study, we have measured CYGB gene expression and promoter methylation in a series of head and neck tumours and determined associations with histopathology, clinical characteristics and established markers of tumour hypoxia such as HIF1A expression and tumour thickness. This evidence concerns the gene HIF1A and head and neck neoplasm.